SCHEMBL30906402

CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)[C@@H](C)O

nearest known ligand 0.61

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	VIPR1	P32241	4/20	0.61

▸	GLP1R	P43220	3/20	0.59

▸	GCGR	P47871	1/20	0.59

▸	GIPR	P48546	1/20	0.59

▸	VIPR2	P41587	6/20	0.58

▸	TFPI	P10646	1/20	0.57

▸	KISS1R	Q969F8	3/20	0.55

▸	CCKBR	P32239	1/20	0.55

▸	ECE1	P42892	1/20	0.54

▸	MUS81	Q96NY9	1/20	0.54

▸	BACE1	P56817	1/20	0.53

▸	BACE2	Q9Y5Z0	1/20	0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30726538	0.96	GLP1R (0.58)	VIPR1GLP1RGCGRGIPRVIPR2
SCHEMBL30648493	0.94	GLP1R (0.58)	VIPR1GLP1RGCGRGIPRVIPR2
SCHEMBL38665420	0.94	GLP1R (0.58)	VIPR1GLP1RGCGRGIPRVIPR2
SCHEMBL29913894	0.92	VIPR1 (0.61)	VIPR1GLP1RGCGRGIPRVIPR2
SCHEMBL30567731	0.92	GLP1R (0.57)	VIPR1GLP1RGCGRGIPRVIPR2
SCHEMBL30038758	0.91	VIPR1 (0.63)	VIPR1GLP1RGCGRGIPRVIPR2
SCHEMBL31672198	0.91	BACE1 (0.62)	VIPR1GLP1RGCGRGIPRVIPR2
SCHEMBL29479828	0.90	VIPR2 (0.58)	VIPR1GLP1RGCGRGIPRVIPR2
SCHEMBL29479821	0.90	TFPI (0.62)	VIPR1GLP1RVIPR2TFPIKISS1R
SCHEMBL29453341	0.90	VIPR1 (0.72)	VIPR1GLP1RGCGRGIPRVIPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed